Hypersensitivity: IgE, Immune Mechanisms and Adrenaline | Part 1 | 過敏 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

The classical hypersensitivity framework organises immune-mediated injury by the effector involved,
the target recognised and the mechanism through which damage occurs.
The Gell and Coombs framework yields four answers.
Type I is immediate and IgE-mediated, acting through mast cells within minutes.
Type II is antibody directed at cell-surface antigens,
either destroying the cell through complement or antibody-dependent cytotoxicity,
or altering receptor function.
Graves disease and myasthenia gravis belong here,
not to Type I or III.
Type III is deposition of immune complexes,
recruiting complement and neutrophils over days, as in serum sickness and lupus.
Type IV alone is antibody-independent.
T cells and macrophages produce contact dermatitis,
the tuberculin response and graft rejection at 48 to 72 hours.

Type I hypersensitivity is a two-act play.
In the sensitisation phase,
dendritic cells present the allergen to naive CD4 cells in an IL-4-rich environment,
which drives differentiation towards Th2.
IL-4 instructs B cells to switch class to IgE.
That IgE occupies the high-affinity receptor FcεRI on mast cells and basophils
and waits.
On re-exposure the allergen cross-links adjacent IgE molecules and triggers degranulation.
Preformed histamine and tryptase are released at once,
while leukotrienes C4 and D4 and prostaglandins are synthesised within minutes.
Smooth muscle contracts, vessels dilate and leak, and mucus pours.
Four to eight hours later, IL-5 recruits eosinophils for the late-phase response.

The immediate and late phases are therefore one mechanism in two tempos,
not two types.

The classical hypersensitivity framework organises immune-mediated injury by the effector involved,
the target recognised and the mechanism through which damage occurs.


Anaphylaxis is that mechanism expressed systemically,
and its treatment has a single first line.
Adrenaline at 0.01 mg/kg,
to a maximum of 0.5 mg of the 1:1000 solution,
is injected intramuscularly into the anterolateral thigh
and repeated every five minutes if needed.
Alpha-1 stimulation restores vascular tone, beta-1 supports the heart, beta-2 relaxes bronchi,
and mast cell release is suppressed.
The patient lies flat, because standing can precipitate cardiovascular collapse.
Oxygen and 20 mL/kg of crystalloid follow for hypotension.
Antihistamines relieve only itch, corticosteroids have no proven role,
and intravenous bolus adrenaline is reserved for cardiac arrest.
Serum tryptase within one to two hours, compared with a baseline sample,
confirms mast cell degranulation.

Not every swelling is histamine.
Chronic spontaneous urticaria itches, wheals and responds to second-generation antihistamines,
escalated to four times the licensed dose and then omalizumab.
Hereditary angioedema, by contrast, is painless, non-itchy and unresponsive to antihistamines,
because deficient C1 inhibitor allows bradykinin to accumulate.
A low C4 level screens for it,
and treatment is C1 inhibitor concentrate or icatibant.

Allergic diseases are rising as environments become cleaner.
The hygiene hypothesis proposes that reduced microbial exposure in infancy leaves Th1 immunity underdeveloped
and tilts the balance towards Th2.
Prolonged antibiotic use therefore increases, rather than reduces, the risk of asthma.
House dust mite remains the most important inhaled allergen,
and it is visible under an ordinary light microscope.

The classical hypersensitivity framework organises immune-mediated injury by the effector involved,
the target recognised and the mechanism through which damage occurs.

Medical Notes · 醫學學習提示

  1. 過敏反應分類依免疫效應、標的及損傷機轉
  2. 分清楚哪種免疫成分攻擊何種標的
  3. 傳統Gell–Coombs分類分為四型
  4. 第一型:IgE與肥大細胞介導速發反應
  5. 第二型:抗體針對細胞表面或基質抗原
  6. 可經補體或抗體依賴細胞毒殺造成損傷
  7. 抗體也可刺激或阻斷受體功能
  8. 葛瑞夫茲病與重症肌無力屬第二型機轉
  9. 受體型自體抗體並非第一型或第三型
  10. 第三型:免疫複合體沉積引起發炎
  11. 補體與嗜中性球參與;如血清病及部分狼瘡損傷
  12. 第四型主要由T細胞介導;本圖僅示第一型肥大細胞
  13. 接觸性皮膚炎由T細胞介導;非圖中的肥大細胞
  14. 結核菌素反應常48–72小時;移植排斥時程不固定
  15. 第一型分為致敏與再次暴露後反應
  16. 致敏時先建立過敏原特異性免疫反應
  17. 樹突細胞呈現抗原促進Th2;圖示下游肥大細胞
  18. 初始CD4細胞朝Th2方向分化
  19. IL-4促進B細胞轉換產生IgE
  20. IgE結合肥大細胞與嗜鹼性球的高親和力FcεRI
  21. 致敏本身不一定立即出現症狀
  22. 再暴露時過敏原交聯IgE,促使肥大細胞脫顆粒
  23. 組織胺與tryptase為預存介質
  24. 白三烯與前列腺素等脂質介質隨後合成
  25. 支氣管收縮、血管擴張滲漏與黏液增加
  26. 遲發期IL-5與嗜酸性球參與;圖中為肥大細胞
  27. 立即與遲發相可同屬第一型反應
  28. 遲發相不等於第四型遲發型過敏
  29. 分類重點是免疫效應與損傷機轉
  30. 確認標的與機轉,才能理解表現
  31. 全身性過敏可由IgE或其他機轉引發
  32. 疑似全身性過敏:立即求援並給第一線腎上腺素
  33. 肌注腎上腺素0.01 mg/kg,依體重計算
  34. 每次上限0.5 mg;1:1000即1 mg/mL
  35. 注射於大腿中段前外側的肌肉
  36. 必要時每五分鐘重複,持續評估呼吸與循環
  37. α1收縮血管、β1支持心臟、β2舒張支氣管
  38. 腎上腺素亦減少肥大細胞介質釋放
  39. 避免站立或行走;呼吸困難可腿伸直坐起
  40. 給氧;低血壓可補等張晶體液20 mL/kg並重評
  41. 抗組織胺僅緩解皮膚症狀;類固醇非第一線
  42. 勿常規靜推腎上腺素;難治型由專家監測輸注
  43. 急性tryptase約1–2小時採樣,與恢復後基線比較
  44. 升高支持肥大細胞活化;正常不能排除全身性過敏
  45. 血管性水腫不一定由組織胺造成
  46. 慢性自發性蕁麻疹可先用第二代H1抗組織胺
  47. 醫師指導可增至四倍;仍未控制再評估Omalizumab
  48. 遺傳性血管性水腫通常不癢,但可有劇烈腹痛
  49. 常見型為C1抑制物缺乏或失能;也有正常型
  50. 合驗C4、C1抑制物濃度與功能;正常C4不能全排除
  51. 急性發作可用C1抑制物或Icatibant;喉頭水腫須急救
  52. 過敏增加涉及多重環境與宿主因素
  53. 衛生假說涉及早期微生物暴露與免疫調節
  54. Th1/Th2失衡僅是簡化解釋,尚涉及免疫耐受
  55. 抗生素暴露與氣喘有關聯,不等於已證實直接因果
  56. 塵蟎是重要吸入性過敏原之一,依地區與個人而異
  57. 塵蟎可用光學顯微鏡觀察;本圖為免疫反應示意
  58. 回顧四型過敏:辨認效應細胞與免疫機轉
  59. 整合免疫標的與損傷方式,而非只背反應時間

References